nodes	percent_of_prediction	percent_of_DWPC	metapath
Tiagabine—CYP3A4—Everolimus—kidney cancer	0.151	0.293	CbGbCtD
Tiagabine—CYP3A4—Temsirolimus—kidney cancer	0.102	0.198	CbGbCtD
Tiagabine—CYP3A4—Pazopanib—kidney cancer	0.0535	0.104	CbGbCtD
Tiagabine—CYP3A4—Erlotinib—kidney cancer	0.0382	0.0741	CbGbCtD
Tiagabine—CYP3A4—Paclitaxel—kidney cancer	0.0349	0.0678	CbGbCtD
Tiagabine—CYP3A4—Sorafenib—kidney cancer	0.031	0.0603	CbGbCtD
Tiagabine—CYP3A4—Vinblastine—kidney cancer	0.0306	0.0595	CbGbCtD
Tiagabine—CYP3A4—Vincristine—kidney cancer	0.0301	0.0585	CbGbCtD
Tiagabine—CYP3A4—Sunitinib—kidney cancer	0.0251	0.0488	CbGbCtD
Tiagabine—CYP3A4—Doxorubicin—kidney cancer	0.0188	0.0366	CbGbCtD
Tiagabine—SLC6A1—Monoamine Transport—ACHE—kidney cancer	0.00246	0.0998	CbGpPWpGaD
Tiagabine—SLC6A1—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.00165	0.067	CbGpPWpGaD
Tiagabine—SLC6A1—Monoamine Transport—TSC2—kidney cancer	0.00132	0.0534	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC5A3—kidney cancer	0.00119	0.0483	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—KEAP1—kidney cancer	0.00104	0.0422	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin activation and detoxification—ACY1—kidney cancer	0.000969	0.0393	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	0.00075	0.0305	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—RYR1—kidney cancer	0.000664	0.027	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC5A5—kidney cancer	0.000628	0.0255	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—ALDH1A1—kidney cancer	0.000609	0.0247	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—SLC2A1—kidney cancer	0.000607	0.0246	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—KCNMA1—kidney cancer	0.000588	0.0239	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—ACHE—kidney cancer	0.000567	0.023	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—EGR1—kidney cancer	0.000563	0.0229	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTP1—kidney cancer	0.000506	0.0205	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BCHE—kidney cancer	0.000494	0.0201	CbGpPWpGaD
Tiagabine—SLC6A1—NRF2 pathway—GSTM1—kidney cancer	0.000465	0.0189	CbGpPWpGaD
Tiagabine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—kidney cancer	0.000442	0.0179	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—ACHE—kidney cancer	0.000435	0.0176	CbGpPWpGaD
Tiagabine—CYP3A4—Codeine and Morphine Metabolism—ABCB1—kidney cancer	0.000409	0.0166	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	0.000396	0.0161	CbGpPWpGaD
Tiagabine—SLC6A1—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	0.000382	0.0155	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ANXA2—kidney cancer	0.000381	0.0155	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC5A3—kidney cancer	0.000381	0.0155	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ATP7B—kidney cancer	0.000381	0.0155	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BCHE—kidney cancer	0.000379	0.0154	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—BCHE—kidney cancer	0.000347	0.0141	CbGpPWpGaD
Tiagabine—CYP3A4—Benzo(a)pyrene metabolism—CYP1A1—kidney cancer	0.000342	0.0139	CbGpPWpGaD
Tiagabine—CYP3A4—Tryptophan metabolism—ALDH1A1—kidney cancer	0.000262	0.0106	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—BRAF—kidney cancer	0.000252	0.0102	CbGpPWpGaD
Tiagabine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—kidney cancer	0.000224	0.00908	CbGpPWpGaD
Tiagabine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A1—kidney cancer	0.000216	0.00877	CbGpPWpGaD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—RAF1—kidney cancer	0.000211	0.00855	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—GSTM1—kidney cancer	0.000207	0.00842	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	0.000201	0.00816	CbGpPWpGaD
Tiagabine—CYP3A4—Estrogen metabolism—CYP1A1—kidney cancer	0.000197	0.00798	CbGpPWpGaD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	0.000194	0.00789	CbGpPWpGaD
Tiagabine—SLC6A1—Neuronal System—BRAF—kidney cancer	0.000193	0.00785	CbGpPWpGaD
Tiagabine—CYP3A4—Irinotecan Pathway—APC—kidney cancer	0.000188	0.00765	CbGpPWpGaD
Tiagabine—CYP3A4—Xenobiotics—CYP1A1—kidney cancer	0.000181	0.00734	CbGpPWpGaD
Tiagabine—Asthenia—Sunitinib—kidney cancer	0.00018	0.000391	CcSEcCtD
Tiagabine—Dyspnoea—Gemcitabine—kidney cancer	0.000179	0.000389	CcSEcCtD
Tiagabine—Nausea—Vinblastine—kidney cancer	0.000179	0.000389	CcSEcCtD
Tiagabine—Somnolence—Gemcitabine—kidney cancer	0.000179	0.000388	CcSEcCtD
Tiagabine—Affect lability—Doxorubicin—kidney cancer	0.000178	0.000387	CcSEcCtD
Tiagabine—Migraine—Doxorubicin—kidney cancer	0.000178	0.000387	CcSEcCtD
Tiagabine—Nausea—Everolimus—kidney cancer	0.000178	0.000387	CcSEcCtD
Tiagabine—Diarrhoea—Sorafenib—kidney cancer	0.000178	0.000387	CcSEcCtD
Tiagabine—Hypertension—Paclitaxel—kidney cancer	0.000178	0.000387	CcSEcCtD
Tiagabine—Pruritus—Sunitinib—kidney cancer	0.000177	0.000385	CcSEcCtD
Tiagabine—Arthralgia—Paclitaxel—kidney cancer	0.000176	0.000382	CcSEcCtD
Tiagabine—Myalgia—Paclitaxel—kidney cancer	0.000176	0.000382	CcSEcCtD
Tiagabine—Chest pain—Paclitaxel—kidney cancer	0.000176	0.000382	CcSEcCtD
Tiagabine—Anxiety—Paclitaxel—kidney cancer	0.000175	0.00038	CcSEcCtD
Tiagabine—Face oedema—Doxorubicin—kidney cancer	0.000175	0.00038	CcSEcCtD
Tiagabine—Decreased appetite—Gemcitabine—kidney cancer	0.000175	0.00038	CcSEcCtD
Tiagabine—Hypersensitivity—Dactinomycin—kidney cancer	0.000175	0.00038	CcSEcCtD
Tiagabine—Chills—Capecitabine—kidney cancer	0.000175	0.000379	CcSEcCtD
Tiagabine—CYP3A4—Tamoxifen metabolism—CYP1A1—kidney cancer	0.000174	0.00706	CbGpPWpGaD
Tiagabine—Discomfort—Paclitaxel—kidney cancer	0.000174	0.000377	CcSEcCtD
Tiagabine—Fatigue—Gemcitabine—kidney cancer	0.000173	0.000377	CcSEcCtD
Tiagabine—Gastrointestinal pain—Vincristine—kidney cancer	0.000173	0.000377	CcSEcCtD
Tiagabine—Dizziness—Sorafenib—kidney cancer	0.000172	0.000374	CcSEcCtD
Tiagabine—Constipation—Gemcitabine—kidney cancer	0.000172	0.000374	CcSEcCtD
Tiagabine—Pain—Gemcitabine—kidney cancer	0.000172	0.000374	CcSEcCtD
Tiagabine—Nausea—Erlotinib—kidney cancer	0.000172	0.000374	CcSEcCtD
Tiagabine—Alopecia—Capecitabine—kidney cancer	0.000172	0.000373	CcSEcCtD
Tiagabine—Dry mouth—Paclitaxel—kidney cancer	0.000172	0.000373	CcSEcCtD
Tiagabine—Mood swings—Doxorubicin—kidney cancer	0.000172	0.000373	CcSEcCtD
Tiagabine—Diarrhoea—Sunitinib—kidney cancer	0.000172	0.000373	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—ALDH1A1—kidney cancer	0.000171	0.00696	CbGpPWpGaD
Tiagabine—Ataxia—Doxorubicin—kidney cancer	0.00017	0.00037	CcSEcCtD
Tiagabine—Asthenia—Dactinomycin—kidney cancer	0.00017	0.00037	CcSEcCtD
Tiagabine—Confusional state—Paclitaxel—kidney cancer	0.00017	0.000369	CcSEcCtD
Tiagabine—Dehydration—Doxorubicin—kidney cancer	0.000169	0.000366	CcSEcCtD
Tiagabine—Oedema—Paclitaxel—kidney cancer	0.000168	0.000366	CcSEcCtD
Tiagabine—Abdominal pain—Vincristine—kidney cancer	0.000168	0.000364	CcSEcCtD
Tiagabine—Body temperature increased—Vincristine—kidney cancer	0.000168	0.000364	CcSEcCtD
Tiagabine—Liver function test abnormal—Doxorubicin—kidney cancer	0.000167	0.000363	CcSEcCtD
Tiagabine—Infection—Paclitaxel—kidney cancer	0.000167	0.000363	CcSEcCtD
Tiagabine—Flatulence—Capecitabine—kidney cancer	0.000167	0.000362	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—ACY1—kidney cancer	0.000166	0.00675	CbGpPWpGaD
Tiagabine—Dry skin—Doxorubicin—kidney cancer	0.000166	0.000361	CcSEcCtD
Tiagabine—Dysgeusia—Capecitabine—kidney cancer	0.000166	0.00036	CcSEcCtD
Tiagabine—Dizziness—Sunitinib—kidney cancer	0.000166	0.00036	CcSEcCtD
Tiagabine—Feeling abnormal—Gemcitabine—kidney cancer	0.000166	0.00036	CcSEcCtD
Tiagabine—Shock—Paclitaxel—kidney cancer	0.000166	0.00036	CcSEcCtD
Tiagabine—Vomiting—Sorafenib—kidney cancer	0.000166	0.00036	CcSEcCtD
Tiagabine—Orthostatic hypotension—Doxorubicin—kidney cancer	0.000166	0.00036	CcSEcCtD
Tiagabine—Hypokalaemia—Doxorubicin—kidney cancer	0.000165	0.000358	CcSEcCtD
Tiagabine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000165	0.000358	CcSEcCtD
Tiagabine—Tachycardia—Paclitaxel—kidney cancer	0.000164	0.000357	CcSEcCtD
Tiagabine—Rash—Sorafenib—kidney cancer	0.000164	0.000357	CcSEcCtD
Tiagabine—Dermatitis—Sorafenib—kidney cancer	0.000164	0.000356	CcSEcCtD
Tiagabine—Back pain—Capecitabine—kidney cancer	0.000164	0.000356	CcSEcCtD
Tiagabine—Headache—Sorafenib—kidney cancer	0.000163	0.000354	CcSEcCtD
Tiagabine—Muscle spasms—Capecitabine—kidney cancer	0.000163	0.000354	CcSEcCtD
Tiagabine—Hyperhidrosis—Paclitaxel—kidney cancer	0.000163	0.000354	CcSEcCtD
Tiagabine—Diarrhoea—Dactinomycin—kidney cancer	0.000162	0.000353	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—RAF1—kidney cancer	0.000161	0.00655	CbGpPWpGaD
Tiagabine—Anorexia—Paclitaxel—kidney cancer	0.000161	0.000349	CcSEcCtD
Tiagabine—Gastritis—Doxorubicin—kidney cancer	0.00016	0.000348	CcSEcCtD
Tiagabine—Muscular weakness—Doxorubicin—kidney cancer	0.00016	0.000347	CcSEcCtD
Tiagabine—Vomiting—Sunitinib—kidney cancer	0.000159	0.000346	CcSEcCtD
Tiagabine—Body temperature increased—Gemcitabine—kidney cancer	0.000159	0.000345	CcSEcCtD
Tiagabine—Tremor—Capecitabine—kidney cancer	0.000159	0.000345	CcSEcCtD
Tiagabine—Rash—Sunitinib—kidney cancer	0.000158	0.000343	CcSEcCtD
Tiagabine—Dermatitis—Sunitinib—kidney cancer	0.000158	0.000343	CcSEcCtD
Tiagabine—Hypotension—Paclitaxel—kidney cancer	0.000157	0.000342	CcSEcCtD
Tiagabine—Ill-defined disorder—Capecitabine—kidney cancer	0.000157	0.000341	CcSEcCtD
Tiagabine—Headache—Sunitinib—kidney cancer	0.000157	0.000341	CcSEcCtD
Tiagabine—Asthma—Doxorubicin—kidney cancer	0.000157	0.00034	CcSEcCtD
Tiagabine—Influenza—Doxorubicin—kidney cancer	0.000157	0.00034	CcSEcCtD
Tiagabine—Dysphagia—Doxorubicin—kidney cancer	0.000157	0.00034	CcSEcCtD
Tiagabine—Anaemia—Capecitabine—kidney cancer	0.000157	0.00034	CcSEcCtD
Tiagabine—Hypersensitivity—Vincristine—kidney cancer	0.000156	0.000339	CcSEcCtD
Tiagabine—Nausea—Sorafenib—kidney cancer	0.000155	0.000336	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000153	0.000333	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—ABCB1—kidney cancer	0.000153	0.00623	CbGpPWpGaD
Tiagabine—Malaise—Capecitabine—kidney cancer	0.000153	0.000332	CcSEcCtD
Tiagabine—Angina pectoris—Doxorubicin—kidney cancer	0.000153	0.000331	CcSEcCtD
Tiagabine—Insomnia—Paclitaxel—kidney cancer	0.000152	0.000331	CcSEcCtD
Tiagabine—Vertigo—Capecitabine—kidney cancer	0.000152	0.00033	CcSEcCtD
Tiagabine—Asthenia—Vincristine—kidney cancer	0.000152	0.00033	CcSEcCtD
Tiagabine—Syncope—Capecitabine—kidney cancer	0.000152	0.00033	CcSEcCtD
Tiagabine—Leukopenia—Capecitabine—kidney cancer	0.000152	0.000329	CcSEcCtD
Tiagabine—Paraesthesia—Paclitaxel—kidney cancer	0.000151	0.000328	CcSEcCtD
Tiagabine—Vomiting—Dactinomycin—kidney cancer	0.000151	0.000328	CcSEcCtD
Tiagabine—Bronchitis—Doxorubicin—kidney cancer	0.000151	0.000327	CcSEcCtD
Tiagabine—Dyspnoea—Paclitaxel—kidney cancer	0.00015	0.000326	CcSEcCtD
Tiagabine—Somnolence—Paclitaxel—kidney cancer	0.00015	0.000325	CcSEcCtD
Tiagabine—Palpitations—Capecitabine—kidney cancer	0.00015	0.000325	CcSEcCtD
Tiagabine—Rash—Dactinomycin—kidney cancer	0.00015	0.000325	CcSEcCtD
Tiagabine—Nausea—Sunitinib—kidney cancer	0.000149	0.000323	CcSEcCtD
Tiagabine—Loss of consciousness—Capecitabine—kidney cancer	0.000149	0.000323	CcSEcCtD
Tiagabine—Dyspepsia—Paclitaxel—kidney cancer	0.000148	0.000322	CcSEcCtD
Tiagabine—Cough—Capecitabine—kidney cancer	0.000148	0.000321	CcSEcCtD
Tiagabine—Dysuria—Doxorubicin—kidney cancer	0.000146	0.000318	CcSEcCtD
Tiagabine—Decreased appetite—Paclitaxel—kidney cancer	0.000146	0.000318	CcSEcCtD
Tiagabine—Hypertension—Capecitabine—kidney cancer	0.000146	0.000318	CcSEcCtD
Tiagabine—Fatigue—Paclitaxel—kidney cancer	0.000145	0.000315	CcSEcCtD
Tiagabine—Diarrhoea—Vincristine—kidney cancer	0.000145	0.000315	CcSEcCtD
Tiagabine—Pollakiuria—Doxorubicin—kidney cancer	0.000145	0.000314	CcSEcCtD
Tiagabine—SLC6A1—Transmission across Chemical Synapses—MAPK1—kidney cancer	0.000144	0.00586	CbGpPWpGaD
Tiagabine—Asthenia—Gemcitabine—kidney cancer	0.000144	0.000313	CcSEcCtD
Tiagabine—Myalgia—Capecitabine—kidney cancer	0.000144	0.000313	CcSEcCtD
Tiagabine—Chest pain—Capecitabine—kidney cancer	0.000144	0.000313	CcSEcCtD
Tiagabine—Arthralgia—Capecitabine—kidney cancer	0.000144	0.000313	CcSEcCtD
Tiagabine—Pain—Paclitaxel—kidney cancer	0.000144	0.000313	CcSEcCtD
Tiagabine—Constipation—Paclitaxel—kidney cancer	0.000144	0.000313	CcSEcCtD
Tiagabine—Anxiety—Capecitabine—kidney cancer	0.000144	0.000312	CcSEcCtD
Tiagabine—Photosensitivity reaction—Doxorubicin—kidney cancer	0.000143	0.000311	CcSEcCtD
Tiagabine—Weight increased—Doxorubicin—kidney cancer	0.000143	0.00031	CcSEcCtD
Tiagabine—Discomfort—Capecitabine—kidney cancer	0.000142	0.000309	CcSEcCtD
Tiagabine—Pruritus—Gemcitabine—kidney cancer	0.000142	0.000309	CcSEcCtD
Tiagabine—Weight decreased—Doxorubicin—kidney cancer	0.000142	0.000308	CcSEcCtD
Tiagabine—Hyperglycaemia—Doxorubicin—kidney cancer	0.000141	0.000307	CcSEcCtD
Tiagabine—Dry mouth—Capecitabine—kidney cancer	0.000141	0.000306	CcSEcCtD
Tiagabine—Nausea—Dactinomycin—kidney cancer	0.000141	0.000306	CcSEcCtD
Tiagabine—Pneumonia—Doxorubicin—kidney cancer	0.00014	0.000305	CcSEcCtD
Tiagabine—Dizziness—Vincristine—kidney cancer	0.00014	0.000305	CcSEcCtD
Tiagabine—Confusional state—Capecitabine—kidney cancer	0.000139	0.000303	CcSEcCtD
Tiagabine—Feeling abnormal—Paclitaxel—kidney cancer	0.000139	0.000301	CcSEcCtD
Tiagabine—Oedema—Capecitabine—kidney cancer	0.000138	0.0003	CcSEcCtD
Tiagabine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000138	0.000299	CcSEcCtD
Tiagabine—Diarrhoea—Gemcitabine—kidney cancer	0.000138	0.000299	CcSEcCtD
Tiagabine—Renal failure—Doxorubicin—kidney cancer	0.000137	0.000298	CcSEcCtD
Tiagabine—Infection—Capecitabine—kidney cancer	0.000137	0.000298	CcSEcCtD
Tiagabine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000137	0.000297	CcSEcCtD
Tiagabine—Stomatitis—Doxorubicin—kidney cancer	0.000136	0.000296	CcSEcCtD
Tiagabine—Shock—Capecitabine—kidney cancer	0.000136	0.000295	CcSEcCtD
Tiagabine—Urinary tract infection—Doxorubicin—kidney cancer	0.000136	0.000295	CcSEcCtD
Tiagabine—Conjunctivitis—Doxorubicin—kidney cancer	0.000136	0.000295	CcSEcCtD
Tiagabine—Thrombocytopenia—Capecitabine—kidney cancer	0.000135	0.000294	CcSEcCtD
Tiagabine—Tachycardia—Capecitabine—kidney cancer	0.000135	0.000293	CcSEcCtD
Tiagabine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—kidney cancer	0.000135	0.00547	CbGpPWpGaD
Tiagabine—Vomiting—Vincristine—kidney cancer	0.000135	0.000293	CcSEcCtD
Tiagabine—Sweating—Doxorubicin—kidney cancer	0.000134	0.000291	CcSEcCtD
Tiagabine—Urticaria—Paclitaxel—kidney cancer	0.000134	0.000291	CcSEcCtD
Tiagabine—Rash—Vincristine—kidney cancer	0.000134	0.00029	CcSEcCtD
Tiagabine—Hyperhidrosis—Capecitabine—kidney cancer	0.000134	0.00029	CcSEcCtD
Tiagabine—Dermatitis—Vincristine—kidney cancer	0.000134	0.00029	CcSEcCtD
Tiagabine—Haematuria—Doxorubicin—kidney cancer	0.000133	0.000289	CcSEcCtD
Tiagabine—Abdominal pain—Paclitaxel—kidney cancer	0.000133	0.000289	CcSEcCtD
Tiagabine—Body temperature increased—Paclitaxel—kidney cancer	0.000133	0.000289	CcSEcCtD
Tiagabine—Headache—Vincristine—kidney cancer	0.000133	0.000288	CcSEcCtD
Tiagabine—Epistaxis—Doxorubicin—kidney cancer	0.000132	0.000286	CcSEcCtD
Tiagabine—Anorexia—Capecitabine—kidney cancer	0.000132	0.000286	CcSEcCtD
Tiagabine—Sinusitis—Doxorubicin—kidney cancer	0.000131	0.000285	CcSEcCtD
Tiagabine—Hypotension—Capecitabine—kidney cancer	0.000129	0.00028	CcSEcCtD
Tiagabine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—kidney cancer	0.000128	0.00522	CbGpPWpGaD
Tiagabine—Vomiting—Gemcitabine—kidney cancer	0.000128	0.000278	CcSEcCtD
Tiagabine—Rash—Gemcitabine—kidney cancer	0.000127	0.000275	CcSEcCtD
Tiagabine—Dermatitis—Gemcitabine—kidney cancer	0.000127	0.000275	CcSEcCtD
Tiagabine—Haemoglobin—Doxorubicin—kidney cancer	0.000126	0.000274	CcSEcCtD
Tiagabine—Headache—Gemcitabine—kidney cancer	0.000126	0.000274	CcSEcCtD
Tiagabine—Nausea—Vincristine—kidney cancer	0.000126	0.000274	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000126	0.000273	CcSEcCtD
Tiagabine—Rhinitis—Doxorubicin—kidney cancer	0.000126	0.000273	CcSEcCtD
Tiagabine—Haemorrhage—Doxorubicin—kidney cancer	0.000125	0.000272	CcSEcCtD
Tiagabine—Insomnia—Capecitabine—kidney cancer	0.000125	0.000271	CcSEcCtD
Tiagabine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000125	0.000271	CcSEcCtD
Tiagabine—Pharyngitis—Doxorubicin—kidney cancer	0.000124	0.00027	CcSEcCtD
Tiagabine—Paraesthesia—Capecitabine—kidney cancer	0.000124	0.00027	CcSEcCtD
Tiagabine—Hypersensitivity—Paclitaxel—kidney cancer	0.000124	0.000269	CcSEcCtD
Tiagabine—Oedema peripheral—Doxorubicin—kidney cancer	0.000124	0.000268	CcSEcCtD
Tiagabine—Dyspnoea—Capecitabine—kidney cancer	0.000123	0.000268	CcSEcCtD
Tiagabine—Dyspepsia—Capecitabine—kidney cancer	0.000122	0.000264	CcSEcCtD
Tiagabine—Visual impairment—Doxorubicin—kidney cancer	0.000121	0.000262	CcSEcCtD
Tiagabine—Asthenia—Paclitaxel—kidney cancer	0.000121	0.000262	CcSEcCtD
Tiagabine—Decreased appetite—Capecitabine—kidney cancer	0.00012	0.000261	CcSEcCtD
Tiagabine—Nausea—Gemcitabine—kidney cancer	0.000119	0.000259	CcSEcCtD
Tiagabine—Fatigue—Capecitabine—kidney cancer	0.000119	0.000259	CcSEcCtD
Tiagabine—Pruritus—Paclitaxel—kidney cancer	0.000119	0.000259	CcSEcCtD
Tiagabine—Pain—Capecitabine—kidney cancer	0.000118	0.000257	CcSEcCtD
Tiagabine—Constipation—Capecitabine—kidney cancer	0.000118	0.000257	CcSEcCtD
Tiagabine—Tinnitus—Doxorubicin—kidney cancer	0.000117	0.000254	CcSEcCtD
Tiagabine—Diarrhoea—Paclitaxel—kidney cancer	0.000115	0.00025	CcSEcCtD
Tiagabine—Feeling abnormal—Capecitabine—kidney cancer	0.000114	0.000247	CcSEcCtD
Tiagabine—Gastrointestinal pain—Capecitabine—kidney cancer	0.000113	0.000245	CcSEcCtD
Tiagabine—Chills—Doxorubicin—kidney cancer	0.000113	0.000244	CcSEcCtD
Tiagabine—Dizziness—Paclitaxel—kidney cancer	0.000111	0.000242	CcSEcCtD
Tiagabine—Alopecia—Doxorubicin—kidney cancer	0.000111	0.000241	CcSEcCtD
Tiagabine—SLC6A1—Neuronal System—MAPK1—kidney cancer	0.000111	0.00449	CbGpPWpGaD
Tiagabine—Urticaria—Capecitabine—kidney cancer	0.00011	0.000238	CcSEcCtD
Tiagabine—Abdominal pain—Capecitabine—kidney cancer	0.000109	0.000237	CcSEcCtD
Tiagabine—Body temperature increased—Capecitabine—kidney cancer	0.000109	0.000237	CcSEcCtD
Tiagabine—Flatulence—Doxorubicin—kidney cancer	0.000108	0.000234	CcSEcCtD
Tiagabine—Tension—Doxorubicin—kidney cancer	0.000107	0.000233	CcSEcCtD
Tiagabine—Vomiting—Paclitaxel—kidney cancer	0.000107	0.000233	CcSEcCtD
Tiagabine—Dysgeusia—Doxorubicin—kidney cancer	0.000107	0.000232	CcSEcCtD
Tiagabine—Rash—Paclitaxel—kidney cancer	0.000106	0.000231	CcSEcCtD
Tiagabine—Dermatitis—Paclitaxel—kidney cancer	0.000106	0.00023	CcSEcCtD
Tiagabine—Nervousness—Doxorubicin—kidney cancer	0.000106	0.00023	CcSEcCtD
Tiagabine—Back pain—Doxorubicin—kidney cancer	0.000106	0.000229	CcSEcCtD
Tiagabine—Headache—Paclitaxel—kidney cancer	0.000105	0.000229	CcSEcCtD
Tiagabine—Muscle spasms—Doxorubicin—kidney cancer	0.000105	0.000228	CcSEcCtD
Tiagabine—Hypersensitivity—Capecitabine—kidney cancer	0.000102	0.000221	CcSEcCtD
Tiagabine—Ill-defined disorder—Doxorubicin—kidney cancer	0.000101	0.00022	CcSEcCtD
Tiagabine—Anaemia—Doxorubicin—kidney cancer	0.000101	0.000219	CcSEcCtD
Tiagabine—Agitation—Doxorubicin—kidney cancer	0.0001	0.000218	CcSEcCtD
Tiagabine—Nausea—Paclitaxel—kidney cancer	0.0001	0.000217	CcSEcCtD
Tiagabine—Asthenia—Capecitabine—kidney cancer	9.92e-05	0.000215	CcSEcCtD
Tiagabine—Malaise—Doxorubicin—kidney cancer	9.84e-05	0.000214	CcSEcCtD
Tiagabine—Vertigo—Doxorubicin—kidney cancer	9.81e-05	0.000213	CcSEcCtD
Tiagabine—Syncope—Doxorubicin—kidney cancer	9.79e-05	0.000213	CcSEcCtD
Tiagabine—Pruritus—Capecitabine—kidney cancer	9.78e-05	0.000212	CcSEcCtD
Tiagabine—Leukopenia—Doxorubicin—kidney cancer	9.77e-05	0.000212	CcSEcCtD
Tiagabine—Palpitations—Doxorubicin—kidney cancer	9.65e-05	0.000209	CcSEcCtD
Tiagabine—Loss of consciousness—Doxorubicin—kidney cancer	9.59e-05	0.000208	CcSEcCtD
Tiagabine—Cough—Doxorubicin—kidney cancer	9.52e-05	0.000207	CcSEcCtD
Tiagabine—Diarrhoea—Capecitabine—kidney cancer	9.46e-05	0.000205	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	9.44e-05	0.00383	CbGpPWpGaD
Tiagabine—Hypertension—Doxorubicin—kidney cancer	9.42e-05	0.000205	CcSEcCtD
Tiagabine—Myalgia—Doxorubicin—kidney cancer	9.29e-05	0.000202	CcSEcCtD
Tiagabine—Arthralgia—Doxorubicin—kidney cancer	9.29e-05	0.000202	CcSEcCtD
Tiagabine—Chest pain—Doxorubicin—kidney cancer	9.29e-05	0.000202	CcSEcCtD
Tiagabine—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	9.28e-05	0.00377	CbGpPWpGaD
Tiagabine—Anxiety—Doxorubicin—kidney cancer	9.26e-05	0.000201	CcSEcCtD
Tiagabine—Discomfort—Doxorubicin—kidney cancer	9.18e-05	0.000199	CcSEcCtD
Tiagabine—Dizziness—Capecitabine—kidney cancer	9.14e-05	0.000198	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	9.11e-05	0.0037	CbGpPWpGaD
Tiagabine—Dry mouth—Doxorubicin—kidney cancer	9.09e-05	0.000197	CcSEcCtD
Tiagabine—Confusional state—Doxorubicin—kidney cancer	8.98e-05	0.000195	CcSEcCtD
Tiagabine—Oedema—Doxorubicin—kidney cancer	8.91e-05	0.000193	CcSEcCtD
Tiagabine—Infection—Doxorubicin—kidney cancer	8.85e-05	0.000192	CcSEcCtD
Tiagabine—Vomiting—Capecitabine—kidney cancer	8.79e-05	0.000191	CcSEcCtD
Tiagabine—Shock—Doxorubicin—kidney cancer	8.76e-05	0.00019	CcSEcCtD
Tiagabine—Thrombocytopenia—Doxorubicin—kidney cancer	8.72e-05	0.000189	CcSEcCtD
Tiagabine—Rash—Capecitabine—kidney cancer	8.71e-05	0.000189	CcSEcCtD
Tiagabine—Dermatitis—Capecitabine—kidney cancer	8.71e-05	0.000189	CcSEcCtD
Tiagabine—Tachycardia—Doxorubicin—kidney cancer	8.69e-05	0.000189	CcSEcCtD
Tiagabine—SLC6A1—Transmembrane transport of small molecules—RAF1—kidney cancer	8.68e-05	0.00352	CbGpPWpGaD
Tiagabine—Headache—Capecitabine—kidney cancer	8.66e-05	0.000188	CcSEcCtD
Tiagabine—Hyperhidrosis—Doxorubicin—kidney cancer	8.61e-05	0.000187	CcSEcCtD
Tiagabine—Anorexia—Doxorubicin—kidney cancer	8.49e-05	0.000184	CcSEcCtD
Tiagabine—Hypotension—Doxorubicin—kidney cancer	8.32e-05	0.000181	CcSEcCtD
Tiagabine—Nausea—Capecitabine—kidney cancer	8.21e-05	0.000178	CcSEcCtD
Tiagabine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	8.12e-05	0.000176	CcSEcCtD
Tiagabine—Insomnia—Doxorubicin—kidney cancer	8.06e-05	0.000175	CcSEcCtD
Tiagabine—Paraesthesia—Doxorubicin—kidney cancer	8e-05	0.000174	CcSEcCtD
Tiagabine—Dyspnoea—Doxorubicin—kidney cancer	7.94e-05	0.000172	CcSEcCtD
Tiagabine—Somnolence—Doxorubicin—kidney cancer	7.92e-05	0.000172	CcSEcCtD
Tiagabine—Dyspepsia—Doxorubicin—kidney cancer	7.84e-05	0.00017	CcSEcCtD
Tiagabine—Decreased appetite—Doxorubicin—kidney cancer	7.74e-05	0.000168	CcSEcCtD
Tiagabine—Fatigue—Doxorubicin—kidney cancer	7.68e-05	0.000167	CcSEcCtD
Tiagabine—Pain—Doxorubicin—kidney cancer	7.62e-05	0.000165	CcSEcCtD
Tiagabine—Constipation—Doxorubicin—kidney cancer	7.62e-05	0.000165	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.51e-05	0.00305	CbGpPWpGaD
Tiagabine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.41e-05	0.00301	CbGpPWpGaD
Tiagabine—Feeling abnormal—Doxorubicin—kidney cancer	7.34e-05	0.000159	CcSEcCtD
Tiagabine—Gastrointestinal pain—Doxorubicin—kidney cancer	7.28e-05	0.000158	CcSEcCtD
Tiagabine—Urticaria—Doxorubicin—kidney cancer	7.08e-05	0.000154	CcSEcCtD
Tiagabine—Body temperature increased—Doxorubicin—kidney cancer	7.04e-05	0.000153	CcSEcCtD
Tiagabine—Abdominal pain—Doxorubicin—kidney cancer	7.04e-05	0.000153	CcSEcCtD
Tiagabine—Hypersensitivity—Doxorubicin—kidney cancer	6.56e-05	0.000143	CcSEcCtD
Tiagabine—Asthenia—Doxorubicin—kidney cancer	6.39e-05	0.000139	CcSEcCtD
Tiagabine—Pruritus—Doxorubicin—kidney cancer	6.3e-05	0.000137	CcSEcCtD
Tiagabine—Diarrhoea—Doxorubicin—kidney cancer	6.09e-05	0.000132	CcSEcCtD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	6.09e-05	0.00247	CbGpPWpGaD
Tiagabine—Dizziness—Doxorubicin—kidney cancer	5.89e-05	0.000128	CcSEcCtD
Tiagabine—Vomiting—Doxorubicin—kidney cancer	5.66e-05	0.000123	CcSEcCtD
Tiagabine—Rash—Doxorubicin—kidney cancer	5.62e-05	0.000122	CcSEcCtD
Tiagabine—Dermatitis—Doxorubicin—kidney cancer	5.61e-05	0.000122	CcSEcCtD
Tiagabine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.6e-05	0.00227	CbGpPWpGaD
Tiagabine—Headache—Doxorubicin—kidney cancer	5.58e-05	0.000121	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	5.35e-05	0.00217	CbGpPWpGaD
Tiagabine—Nausea—Doxorubicin—kidney cancer	5.29e-05	0.000115	CcSEcCtD
Tiagabine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	5.02e-05	0.00204	CbGpPWpGaD
Tiagabine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.54e-05	0.00184	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	3.71e-05	0.00151	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	3.66e-05	0.00149	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	3.41e-05	0.00138	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	3.36e-05	0.00137	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	3.23e-05	0.00131	CbGpPWpGaD
Tiagabine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	3.19e-05	0.00129	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACY1—kidney cancer	2.84e-05	0.00115	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PDHB—kidney cancer	2.42e-05	0.000981	CbGpPWpGaD
Tiagabine—CYP3A4—Biological oxidations—POMC—kidney cancer	2.41e-05	0.000978	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CCBL1—kidney cancer	2.27e-05	0.000923	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.97e-05	0.0008	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PPAT—kidney cancer	1.97e-05	0.0008	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—FH—kidney cancer	1.83e-05	0.000744	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—APRT—kidney cancer	1.83e-05	0.000744	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GPC3—kidney cancer	1.72e-05	0.000699	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA2—kidney cancer	1.68e-05	0.00068	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALAD—kidney cancer	1.63e-05	0.000663	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.59e-05	0.000647	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.56e-05	0.000632	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PGK1—kidney cancer	1.49e-05	0.000606	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.49e-05	0.000606	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—LDHB—kidney cancer	1.46e-05	0.000595	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CA9—kidney cancer	1.27e-05	0.000516	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CRABP1—kidney cancer	1.08e-05	0.000438	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ITPR2—kidney cancer	1e-05	0.000408	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTT1—kidney cancer	9.15e-06	0.000372	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ACHE—kidney cancer	9.15e-06	0.000372	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SCARB1—kidney cancer	8.67e-06	0.000352	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS1—kidney cancer	8.58e-06	0.000348	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PSMD7—kidney cancer	8.41e-06	0.000341	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—BCHE—kidney cancer	7.98e-06	0.000324	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC5A5—kidney cancer	7.88e-06	0.00032	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—SLC2A1—kidney cancer	7.61e-06	0.000309	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTP1—kidney cancer	6.35e-06	0.000258	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—ABCB1—kidney cancer	6.01e-06	0.000244	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—GSTM1—kidney cancer	5.83e-06	0.000237	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—CYP1A1—kidney cancer	5.53e-06	0.000224	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—POMC—kidney cancer	4.12e-06	0.000167	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTGS2—kidney cancer	3.29e-06	0.000133	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PTEN—kidney cancer	2.87e-06	0.000116	CbGpPWpGaD
Tiagabine—CYP3A4—Metabolism—PIK3CA—kidney cancer	2.02e-06	8.21e-05	CbGpPWpGaD
